Role
10%+ Owner
Signature
Wellington Biomedical Innovation Master Investors (Cayman) I L.P., By: Wellington Management Company LLP, as Investment Advisor, /s/ Jennifer Boylan, Title: Authorized Person
Stock symbol
NUVL
Transactions as of
Jul 28, 2021
Transactions value $
$0
Form type
3
Date filed
7/28/2021, 09:29 PM
Previous filing
Jun 22, 2021
Next filing
Aug 3, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NUVL Series B Preferred Stock Jul 28, 2021 Class A Common Stock 898K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series B Preferred Stock is convertible into 0.1858 shares of the Issuer's Class A Common Stock at any time at the holder's election. Upon the closing of the Issuer's initial public offering, all such shares of Series B Preferred Stock will automatically convert into the number of shares of Class A Common Stock of the Issuer shown in column 3. The Series B Preferred Stock has no expiration date.